Epileptic Channelopathies and Neuromuscular Disorders in Newborns: A Narrative Review

Mohammad N Almohammal1

  • 1Department of Pediatrics, Ministry of Health, Bisha, SAU.

Cureus
|September 20, 2023
PubMed

Insights

Early diagnosis of neonatal channelopathies is crucial for preventing developmental delays and death. This review focuses on diagnostic criteria for these ion channel abnormalities affecting newborns.

Area of Science:

  • Neuroscience
  • Genetics
  • Pediatrics

Background:

  • Neonatal channelopathies, ion channel abnormalities, can affect any organ system.
  • These conditions can lead to seizures, developmental delays, and early mortality.
  • Early identification is vital for preventing long-term neurodevelopmental damage in infants.

Purpose of the Study:

  • To review and highlight early diagnostic criteria for neonatal channelopathies.
  • To provide a methodical approach for diagnosing these complex conditions.
  • To address the challenges physicians face in interpreting presenting symptoms.

Main Methods:

  • Review of current literature on neonatal channelopathies and their diagnostics.
  • Focus on voltage-gated sodium channels and their associated genetic mutations.
  • Examination of clinical presentations and diagnostic pathways.

Main Results:

  • Mutations in voltage-gated sodium channel genes cause various pediatric neurological diseases.
  • Clinical manifestations include episodic paralysis, myotonia, hypotonia, respiratory issues, and myopathy.
  • Channelopathies are increasingly recognized as causes of epilepsy syndromes and encephalopathies.

Conclusions:

  • Early and accurate diagnosis of neonatal channelopathies is essential for timely intervention.
  • A systematic diagnostic approach is necessary due to complex and varied presentations.
  • Understanding genetic mutations, particularly in sodium channels, aids in diagnosis and management.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
406
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
212
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
210
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
452
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
990
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K